Tenofovir alafenamide (TAF) is currently administered orally to patients for treatment of chronic hepatitis B virus infection and as a part of a combination therapy for human immunodeficiency virus (HIV) infection. A long-acting delivery system could provide several advantages as a formulation strategy for this drug including improved patient adherence. convenience. more consistent dr... https://www.spidertattooz.com/The-GelBottle-Inc-Gel-Polish-Audrey-67oz-p17921/